Clinical Trial Update: Extracorporal Cytokin Removal in Septic Shock: a Prospective, Randomized, Multicenter Clinical Trial [Phase 3]

View source ↗

Summary

A Phase 3 prospective, randomized multicenter trial evaluating extracorporeal cytokine removal for septic shock; the study is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Snippet

Sponsor: University of Pecs | Conditions: Septic Shock | Phase 3 | Status: SUSPENDED